Skip to content
OpenCapital
Get started

Bicara Therapeutics BCAX Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$7.92M+751%
Nuvation Bio logo
Nuvation BioNUVB
$44K-92.0%
Amgen logo
AmgenAMGN
——
Summit Therapeutics logo
Summit TherapeuticsSMMT
——

Other financials

Income statement

See full
Operating income-$60.2M-44.2%
Net income-$56.2M-52.6%
EPS (diluted)-$0.93-36.8%

Balance sheet

See full
Cash & equivalents$323.5M-30.0%
Total debt$1.4M+144%
Total equity$514.0M+12.0%
Total assets$553.6M+15.8%

Cash flow

See full
Operating cash flow-$37.5M-33.5%
CapEx$60.0K—
Free cash flow-$37.6M-33.7%

Valuation

See full
Market cap$1.68B+81.4%

Returns & leverage

See full
Return on equity-32.3%—
Debt / equity0×0.0×
Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bicara Therapeutics's cash provided by (used in) financing activity, including discontinued operation?
Bicara Therapeutics (BCAX) reported cash provided by (used in) financing activity, including discontinued operation of $163.35M in Q1 2026.
How has Bicara Therapeutics's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Bicara Therapeutics's cash provided by (used in) financing activity, including discontinued operation increased by 35409.8% year-over-year, from $460K to $163.35M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.